RAC 3.77% $1.53 race oncology ltd

Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,752 Posts.
    lightbulb Created with Sketch. 670
    Does this put clinic trials on hold(aml and breast)? More delays before we dose patients. I was under the impression at least an AML trial with the strategic update and a solution to the companies inability to dose a patient.

    Please forgive me if I'm way off track and be sure to correct me. Thx
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.